1-4 of 4
Gang Li
Close
Sort by
Journal Articles

A study of ruxolitinib response–based stratified treatment for pediatric hemophagocytic lymphohistiocytosis

Clinical Trials & Observations
Qing Zhang, Yun-Ze Zhao, Hong-Hao Ma, Dong Wang, Lei Cui, Wei-Jing Li, Ang Wei, Chan-Juan Wang, Tian-You Wang, Zhi-Gang Li, Rui Zhang
Journal: Blood
Blood (2022) 139 (24): 3493–3504.
https://doi.org/10.1182/blood.2021014860
Published: 2022
Includes: Supplemental data
Journal Articles

Increased prevalence of CRLF2 rearrangements in obesity-associated acute lymphoblastic leukemia

Clinical Trials & Observations
Steven D. Mittelman, Jiyoon Kim, Gordana Raca, Gang Li, Matthew J. Oberley, Etan Orgel
Journal: Blood
Blood (2021) 138 (2): 199–202.
https://doi.org/10.1182/blood.2021011106
Published: 2021
Includes: Supplemental data
Journal Articles

Escalating Single Doses of PF-05230907 (Recombinant Factor Xa Variant FXa I16L ) Are Safe and Demonstrate Hemostatic Pharmacology in Healthy Volunteers

Steven Arkin, MD, Fei Hua, PhD, Constantino Kantaridis, MD, Gang Li, PhD, Dana Parsons-Rich, MPH, MPA, Debra D Pittman
Journal: Blood
Blood (2016) 128 (22): 3781.
https://doi.org/10.1182/blood.V128.22.3781.3781
Published: 2016
Journal Articles

Tumor-Derived Chaperone-Rich Cell Lysate (CRCL) Can Be Effectively Combined with Syngeneic Bone Marrow Transplantation to Treat Bcr-abl + Leukemia in a Murine Model.

Xinchun Chen, MD, Yi Zeng, PhD, Gang Li, MD, Sylvia Thompson, Marjan Sepassi, M. Angela Romanoski, Michael W. Graner, PhD, Emmanuel Katsanis, MD
Journal: Blood
Blood (2004) 104 (11): 2971.
https://doi.org/10.1182/blood.V104.11.2971.2971
Published: 2004